Who Paid My Doc
Melanie Rayan
Endocrinology, Diabetes & Metabolism Rapid City, SD Medical Doctor
NPI 1922617869 CMS profile 11885690
640 Flormann St, Rapid City, SD 57701
General payments
$451
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Melanie Rayan of Rapid City, SD is reported in the CMS Open Payments database as having received $451 across 18 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 31st percentile of Endocrinology, Diabetes & Metabolism profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
1 row| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $451 | 18 |
Beside peers
- Melanie Rayan
- Endocrinology, Diabetes & Metabolism median
- Middle half of Endocrinology, Diabetes & Metabolism
- National median
In program year 2025, general payments to Melanie Rayan were reported at $451. Among 5,868 Endocrinology, Diabetes & Metabolism profiles paid that year, the median was $507 and the middle half received between $135 and $1,838.
Show as a table
| Year | Melanie Rayan | Endocrinology, Diabetes & Metabolism median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $494 | $123–$2,253 | $163 |
| 2020 | $0 | $335 | $85–$1,841 | $114 |
| 2021 | $0 | $398 | $88–$1,981 | $132 |
| 2022 | $0 | $364 | $88–$1,568 | $149 |
| 2023 | $0 | $420 | $113–$1,614 | $160 |
| 2024 | $0 | $440 | $121–$1,646 | $164 |
| 2025 | $451 | $507 | $135–$1,838 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 4 drugsPart D claims
61
Drug cost
$26,071
Branded share of claims
57.4%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Trulicity Dulaglutide | Brand | 15 | $17,289 | |
| Tresiba Flextouch U-100 Insulin Degludec | Brand | 20 | $8,431 | |
| Hydrocortisone | Generic | 11 | $291 | |
| Levothyroxine Sodium | Generic | 15 | $60 |
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 104,182 Part D prescribers listed as Internal Medicine; they describe a distribution and say nothing about conduct.
Records
18 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Endocrinology, Diabetes & Metabolism in South Dakota
John Palmer
Endocrinology, Diabetes & Metabolism · Rapid City, SD
Sonalika Khachikian
Endocrinology, Diabetes & Metabolism · Rapid City, SD
Richard Crawford
Endocrinology, Diabetes & Metabolism · Sioux Falls, SD
Brandon Allard
Endocrinology, Diabetes & Metabolism · Sioux Falls, SD
Randall Fenner
Endocrinology, Diabetes & Metabolism · Sioux Falls, SD
Marie Angelica Diaz
Endocrinology, Diabetes & Metabolism · Sioux Falls, SD
Related records
Endocrinology, Diabetes & Metabolism in South Dakota
Practitioners in the same specialty and state, ranked by reported value.
All Endocrinology, Diabetes & Metabolism
Everyone recorded under this specialty, nationwide.
Doctors in South Dakota
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.